Oden Institute for Computational Engineering and Sciences, The University of Texas at Austin, Austin, TX 78712, USA; Departments of Livestrong Cancer Institutes, The University of Texas at Austin, Austin, TX 78712, USA.
Departments of Radiation Oncology, MD Anderson Cancer Center, Houston, TX 77230, USA.
Adv Drug Deliv Rev. 2022 Aug;187:114367. doi: 10.1016/j.addr.2022.114367. Epub 2022 May 30.
Immunotherapy has become a fourth pillar in the treatment of brain tumors and, when combined with radiation therapy, may improve patient outcomes and reduce the neurotoxicity. As with other combination therapies, the identification of a treatment schedule that maximizes the synergistic effect of radiation- and immune-therapy is a fundamental challenge. Mechanism-based mathematical modeling is one promising approach to systematically investigate therapeutic combinations to maximize positive outcomes within a rigorous framework. However, successful clinical translation of model-generated combinations of treatment requires patient-specific data to allow the models to be meaningfully initialized and parameterized. Quantitative imaging techniques have emerged as a promising source of high quality, spatially and temporally resolved data for the development and validation of mathematical models. In this review, we will present approaches to personalize mechanism-based modeling frameworks with patient data, and then discuss how these techniques could be leveraged to improve brain cancer outcomes through patient-specific modeling and optimization of treatment strategies.
免疫疗法已成为脑瘤治疗的第四大支柱,与放射疗法联合使用,可能改善患者预后并降低神经毒性。与其他联合疗法一样,确定最大限度发挥放射和免疫疗法协同作用的治疗方案是一个基本挑战。基于机制的数学建模是一种很有前途的方法,可以在严格的框架内系统地研究治疗组合,以最大限度地提高积极结果。然而,要使基于模型生成的治疗组合成功转化为临床应用,需要患者特异性数据来使模型能够进行有意义的初始化和参数化。定量成像技术已成为开发和验证数学模型的高质量、时空分辨数据的有前途的来源。在这篇综述中,我们将介绍如何使用患者数据对基于机制的建模框架进行个性化设置,然后讨论如何利用这些技术通过患者特异性建模和优化治疗策略来改善脑癌的预后。